GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imeik Technology Development Co Ltd (SZSE:300896) » Definitions » EBIT

Imeik Technology Development Co (SZSE:300896) EBIT : ¥2,294 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Imeik Technology Development Co EBIT?

Imeik Technology Development Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ¥623 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,294 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Imeik Technology Development Co's annualized ROC % for the quarter that ended in Mar. 2024 was 69.42%. Imeik Technology Development Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 429.09%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Imeik Technology Development Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 4.12%.


Imeik Technology Development Co EBIT Historical Data

The historical data trend for Imeik Technology Development Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imeik Technology Development Co EBIT Chart

Imeik Technology Development Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 342.07 472.97 1,123.97 1,491.46 2,157.94

Imeik Technology Development Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 486.34 630.82 533.94 506.84 622.73

Competitive Comparison of Imeik Technology Development Co's EBIT

For the Medical Instruments & Supplies subindustry, Imeik Technology Development Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imeik Technology Development Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imeik Technology Development Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Imeik Technology Development Co's EV-to-EBIT falls into.



Imeik Technology Development Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,294 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imeik Technology Development Co  (SZSE:300896) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Imeik Technology Development Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=2420.28 * ( 1 - 15.11% )/( (2983.717 + 2935.534)/ 2 )
=2054.575692/2959.6255
=69.42 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6852.361 - 230.695 - ( 3637.949 - max(0, 297.668 - 4251.298+3637.949))
=2983.717

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7304.246 - 168.02 - ( 4200.692 - max(0, 224.419 - 4685.32+4200.692))
=2935.534

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Imeik Technology Development Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2490.936/( ( (282.057 + max(318.653, 0)) + (298.853 + max(261.459, 0)) )/ 2 )
=2490.936/( ( 600.71 + 560.312 )/ 2 )
=2490.936/580.511
=429.09 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(206.068 + 49.771 + 345.479) - (230.695 + 0 + 51.97)
=318.653

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(151.357 + 45.194 + 271.809) - (168.02 + 0 + 38.881)
=261.459

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Imeik Technology Development Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=2294.332/55733.254
=4.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imeik Technology Development Co EBIT Related Terms

Thank you for viewing the detailed overview of Imeik Technology Development Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Imeik Technology Development Co (SZSE:300896) Business Description

Traded in Other Exchanges
N/A
Address
No. Jia 92 Jianguo Road, 21st, Block C, Shimao Building, Chaoyang District, Beijing, CHN, 100022
Imeik Technology Development Co Ltd is a national enterprise focusing on the research and development, manufacture and sales of biomedical materials. The company's products include Medical Cosmetic Platform; General Surgery Platform; and Biological Technology Platform.
Executives
Jian Jun Director
Wang Lan Zhu Director
Zhang Zheng Pu Supervisors

Imeik Technology Development Co (SZSE:300896) Headlines

No Headlines